A carregar...
Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S Patients
Leucine-rich repeat kinase 2 (LRRK2) mutations are among the most significant genetic risk factors for developing late onset Parkinson’s disease (PD). To understand whether a therapeutic can modulate LRRK2 levels as a potential disease modifying strategy, it is important to have methods in place to...
Na minha lista:
| Publicado no: | Front Neurosci |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7262382/ https://ncbi.nlm.nih.gov/pubmed/32523511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2020.00526 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|